liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy
Karolinska Institute.
Karolinska Institute.
Karolinska Institute.
Aarhus University Hospital.
Show others and affiliations
2009 (English)In: in Leukemia Research, vol 33, 2009, Vol. 33, S49-S50 p.Conference paper, Published paper (Refereed)
Abstract [en]

n/a

Place, publisher, year, edition, pages
2009. Vol. 33, S49-S50 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-19661OAI: oai:DiVA.org:liu-19661DiVA: diva2:227227
Available from: 2009-07-10 Created: 2009-07-10 Last updated: 2009-07-10

Open Access in DiVA

No full text

Other links

Link to Journal

Authority records BETA

Antunovic, Petar

Search in DiVA

By author/editor
Antunovic, Petar
By organisation
Department of Biomedicine and SurgeryFaculty of Health Sciences
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 26 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf